Kite Realty Group Trust Common Stock (KRG)
22.86
+0.40 (1.78%)
NYSE · Last Trade: Apr 2nd, 7:08 PM EDT
Via Benzinga · March 26, 2025

KRG stock results show that Kite Realty Gr Trust beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 30, 2024

Indications Suggest NYSE:KRG Could Be on the Verge of a Breakout.
Via Chartmill · July 4, 2024

KRG stock results show that Kite Realty Gr Trust met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · April 30, 2024

Home prices defied high mortgage costs and surpassed expectations with a 1.2% month-over-month growth, the largest increase since Apr 2022.
Via Benzinga · April 30, 2024

A technical analysis of KITE REALTY GROUP TRUST (NYSE:KRG) shows it may be setting up for a breakout.
Via Chartmill · August 10, 2023

Via Benzinga · November 12, 2024

Via Benzinga · August 20, 2024

These are a number of great buys for investors who are seeking more exposure to stocks that are within the Russell 2000.
Via InvestorPlace · April 18, 2024

Via Benzinga · April 2, 2024

Via Benzinga · February 20, 2024

Invest in the these seven best REITs to buy offering strong upside and shining bright in 2023's tough real estate market.
Via InvestorPlace · December 7, 2023

Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million.
Via Benzinga · February 13, 2024

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via Benzinga · October 30, 2023

These are seven different REITs that investors should be looking to buy. These companies offer strong performance and steady growth.
Via InvestorPlace · October 19, 2023

Via Benzinga · September 5, 2023

Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.
Via Benzinga · July 31, 2023

Via Benzinga · May 24, 2023

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.
Via Benzinga · May 1, 2023